Compass Gas e Energia (PASS3) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
13 Nov, 2026Executive summary
Adjusted consolidated EBITDA rose 8.4% YoY to R$1.508bn; net income increased 37% to R$591.1m, supported by distribution resilience and stronger normalized Marketing & Services results.
Reported EBITDA reached R$1.637bn, up 22% YoY, boosted by cargo optimization gains; net debt/LTM EBITDA improved to 2.2x from 2.3x in 2Q26.
Financial highlights
Revenue was R$4.128bn, down 3% YoY; gross profit was R$1.168bn, down 1%.
Adjusted gross profit reached R$1.736bn, up 6.7% YoY; gross profit excluding D&A was R$1.528bn, up 3%.
9M26 EBITDA increased 10% to R$4.240bn and net income rose 5% to R$1.261bn.
Net financial expense rose 16% to R$457.3m; excluding the prior-year R$52.8m Necta tariff-review adjustment, it increased 6.6%.
Adjusted SG&A excluding D&A fell 6.7%, excluding R$9.6m of IPO expenses; adjusted EBITDA excludes R$15.1m of IPO expenses.
Outlook and guidance
Deferred optimization gains totaled R$280m for 4Q26 and R$353m for 2027; recognition is normalized to the periods to which gains economically relate.
Edge off-grid contracts totaled ~0.2m m³/day, half the first-phase potential; growth initiatives also include biomethane, gas trading and distribution network expansion.
OneBio’s new production lines began operating in 3Q26 and approached full capacity; the plant was certified to issue CGOB certificates.
Latest events from Compass Gas e Energia
- EBITDA up 44% and net income up 73% in Q2 2024, with major expansion and acquisitions.PASS3
Q2 2024 - Revenue up 13%, EBITDA stable, and key acquisitions completed amid higher leverage.PASS3
Q3 2024 - Net sales up 3.5% to R$18.38B, EBITDA up 17% to R$5.03B, with key portfolio milestones.PASS3
Q4 2024 - EBITDA rose 45% and net income 32% in 1Q25, with strong volumes and higher leverage.PASS3
Q1 2025 - Net revenue was flat, gross profit rose, but net income dropped 41% on higher debt costs.PASS3
Q2 2025 - EBITDA rose, but net sales and profit fell; investments and leverage remained strong.PASS3
Q3 2025 - Recurring EBITDA up 11% to R$5.0B, net profit down 31%, investments R$2.2B, leverage 2.2x.PASS3
Q4 2025 - EBITDA rose 2% to R$1.33B, normalized EBITDA 12%, despite a 25% revenue drop and higher costs.PASS3
Q1 2026 - EBITDA rose 5% year-over-year, but net income dropped 19% to R$ 287 million.PASS3
Q2 2026